NCT02767752View on ClinicalTrials.gov

Gemcitabine and Capecitabine With or Without T-ChOS as Adjuvant Therapy for Patients With Resected Pancreatic Cancer

PHASE2TerminatedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

July 31, 2018

Study Completion Date

July 31, 2018

Conditions
Pancreatic Cancer
Interventions
DIETARY_SUPPLEMENT

T-ChOS

DRUG

Gemcitabine

DIETARY_SUPPLEMENT

Placebo

DRUG

Capecitabine

Trial Locations (1)

2730

Department of Oncology, Herlev

Sponsors

Collaborators (1)

GENIS
All Listed Sponsors
collaborator

GENIS

UNKNOWN

lead

Herlev Hospital

OTHER